Panel Discussion: Totally Drug Resistant TB is here: Are we too late? || HGHI – Barry Bloom, Ph.D., Harvard School of Public Health (Chair); Sarah Fortune, MD, Harvard School of Public Health; Jeremy Greene, MD, Ph.D., Harvard Medical School; Bob Horsburgh, Ph.D., Boston University; Khisimuzi Mdluli, Ph.D., TB Alliance; Scott Podolsky, MD, Harvard Medical School; Zarir Udwadia, MD, Hunduja National Hospital, Mumbai; and Rob Warren, Ph.D., Stellenbosch University, Cape Town A topical discussion to answer how we have arrived at TDR; to discuss new drugs in the pipeline; to consider the ethical and policy considerations surrounding patient treatment; to predict the spread of TDR, and to mobilize our community to devise a strategy to cure people infected with TDR TB. Sixth Annual New England Tuberculosis Symposium Harvard Global Health Institute June 28th, 2012 The Broad Institute 7 Cambridge Center Cambridge, MA

State's pharmacy board jumping ahead of proposed bill

Filed under: drug treatment centers in massachusetts

The rare and potentially fatal illness was linked to contaminated drugs made by New England Compounding Center (NECC) of Framingham, Mass. According to the Centers for Disease Control and Prevention, there were 14 cases of illness in New …
Read more on The Union Leader

'I Don't Smoke, Doc,' and Other Patient Lies

Filed under: drug treatment centers in massachusetts

The same for cigarettes and illicit drugs, doctors say. … Yolanda Reid-Chassiakos, director of the student health center at California State University, Northridge, once saw a college student whose parents suspected she was suffering from anorexia …
Read more on Wall Street Journal

Common Diabetes Drug Could Play a Role in Stroke

Filed under: drug treatment centers in massachusetts

The study included 10 patients with stroke from the University of Maryland and Massachusetts General Hospital who had large stroke volumes, 82 mL or greater on MRI, who were at very high risk for edema and poor outcome. "These are the patients that …
Read more on Medscape